Late Eating Tied to Poor Glucose Tolerance
By Lori Solomon HealthDay Reporter
THURSDAY, Jan. 2, 2025 -- Late consumption of calories is associated with worse glucose tolerance, according to a study published online Oct. 25 in Nutrition & Diabetes.
Diana A. Díaz-Rizzolo, Ph.D., R.D., from the Columbia University Irving Medical Center in New York City, and colleagues investigated the impact of habitual late calorie intake (≥45 percent daily calories consumed after 5 p.m.) on glucose metabolism in 26 adults with overweight or obesity and diet- or metformin-controlled prediabetes or type 2 diabetes.
The researchers found that early and late eaters did not differ in anthropometrics or daily energy intake, but late eaters consumed more carbohydrates and fats after 5 p.m. There were no differences in fasting glucose, insulin, or C-peptide between groups but late eaters exhibited higher glucose concentrations after an oral glucose tolerance test when adjusting for body weight, fat mass, energy intake, and diet composition. When participants with type 2 diabetes were excluded, glucose results remained. Differences in glucose concentrations were higher in late eaters for time 30 and 60 minutes, when adjusting for diabetes status.
"Late eating is associated with greater consumption of calories mostly from carbohydrates and fats and may lead to prolonged evening postprandial glucose excursions contributing to worse glucose tolerance," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
Increasing Proportion of U.S. Adults Unaware They Have Hypertension
MONDAY, June 9, 2025 -- From 2013 to 2023, there was an increase in the proportion of U.S. adults who were unaware of having hypertension, according to a research letter published...
Finerenone + Empagliflozin Offers Greater Benefit in CKD, T2DM
MONDAY, June 9, 2025 -- For patients with chronic kidney disease and type 2 diabetes, combination finerenone plus empagliflozin leads to a greater reduction in the urinary...
Concurrent Hypertension + Type 2 Diabetes Predict High Mortality Risk
WEDNESDAY, June 4, 2025 -- Adults with concurrent hypertension and type 2 diabetes (T2D) have high mortality risk compared with those who have neither condition or only one...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.